| Ytd | 1.18% | |
| 1y | -5.46% |
| Open | 14.25 | Prev Close | 14.11 | Low | 14.13 | High | 14.25 | Mkt Cap | 292.14M |
| Vol | 6.40K | Avg Vol | 73.09K | EPS | -0.10 | P/E | -141.25 | Forward P/E | -2.17 |
| Beta | 0.81 | Short Ratio | 12.75 | Inst. Own | 17.05% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 07-29 | 50-d Avg | 14.79 | 200-d Avg | 15.02 | 1yr Est | 1.00 |
Amarin Corporation plc (AMRN) Q2 2026 Earnings Call Transcript
AMRN surpasses Q2 earnings estimates despite lower revenues, as cost cuts, rising demand and global
Amarin NASDAQ: AMRN said its second-quarter results reflected progress in its dual commercial strate
Amarin Corp (NASDAQ:AMRN) reported quarterly sales of $42.211 million which missed the analyst conse
Q2 2026 Results Highlight Global Volume Growth, Lower Operating Expenses and Positive Cash Flow For
DUBLIN, Ireland and BRIDGEWATER, N.J., July 15, 2026 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NAS
Amarin (AMRN) witnesses a hammer chart pattern, indicating support found by the stock after losing s
Gainers Crinetics Pharmaceuticals (NASDAQ:CRNX) stock increased by 98.9% to $83.59 during Tuesday&#
Amarin Corporation plc (NASDAQ:AMRN), a company committed to advancing the science of cardiovascular
Clinically Validated, Increasingly Prescribed, Widely Reimbursed, and Affordable, VASCEPA Expected t
Here is how Amarin (AMRN) and Amneal Pharmaceuticals (AMRX) have performed compared to their sector
https://www.supremecourt.gov/opinions/25pdf/24-889_5i36.pdf
Amarin Corporation plc (NASDAQ:AMRN) (Amarin), a company committed to advancing the science of cardi
DUBLIN and BRIDGEWATER, N.J., May 27, 2026 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ: AMRN)
Iovance matches Q1 earnings estimates, but weaker-than-expected Amtagvi and Proleukin sales sent sha
Amarin (AMRN) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about t
AMRN beats earnings and sales estimates as Vascepa sales rise and cost cuts take hold, while the par
Amarin Corporation plc (AMRN) Q1 2026 Earnings Call Transcript
Amarin Corp (NASDAQ:AMRN) reported quarterly sales of $45.132 million which beat the analyst consens
Total Revenue Increased Led by Higher International Sales Generated Positive Cash Flow and Reiterate
Here is how Amarin (AMRN) and BioAge Labs, Inc. (BIOA) have performed compared to their sector so fa
DUBLIN and BRIDGEWATER, N.J., April 15, 2026 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ: AMR
Amarin Corporation plc (NASDAQ:AMRN) ("Amarin"), a company committed to advancing the scienc
Amarin has one drug, and it has lost key patent protections. The company is cutting costs in an effo
Amarin shares surge 37.7% in a year as restructuring, cost cuts and expanding Vazkepa partnerships f
Amarin's results depend on a single medicine that is already facing generic competition. By contrast
Peer-reviewed paper indicates icosapent ethyl (IPE) was associated with fewer total hospitalizations
Amarin (NASDAQ: AMRN) executives told investors that 2025 marked a "substantial achievement" year as
Amarin Corp (NASDAQ:AMRN) reported quarterly earnings of $0.01 per share which beat the analyst cons
Shares of Butterfly Network, Inc. (NASDAQ: BFLY) fell sharply during Thursday’s session after the
Companies Reporting Before The Bell • Frontline (NYSE:FRO) is expected to report quarterly earnings
Shares of TechTarget, Inc. (NASDAQ: TTGT) rose sharply during Thursday’s session after the company a
Companies Reporting Before The Bell • GSK (NYSE:GSK) is expected to report quarterly earnings at $1
On Thursday, 369 companies hit new 52-week lows.
On Tuesday, 647 companies set new 52-week lows.
On Tuesday, 386 stocks made new 52-week lows.
During the session on Thursday, 461 stocks hit new 52-week lows.
Companies Reporting Before The Bell • Janus Henderson Gr (NYSE:JHG) is expected to report quarterly
On Thursday, 1076 companies hit new 52-week lows.